{"id":69314,"date":"2021-12-13T00:00:00","date_gmt":"2021-12-13T00:00:00","guid":{"rendered":"https:\/\/medgoo.com\/index.php\/2021\/12\/13\/british-study-shows-vaccines-weaken-against-omicron-but-boosters-help\/"},"modified":"2021-12-15T18:11:51","modified_gmt":"2021-12-15T18:11:51","slug":"british-study-shows-vaccines-weaken-against-omicron-but-boosters-help","status":"publish","type":"post","link":"https:\/\/medgoo.com\/index.php\/2021\/12\/13\/british-study-shows-vaccines-weaken-against-omicron-but-boosters-help\/","title":{"rendered":"British Study Shows Vaccines Weaken Against Omicron, but Boosters Help"},"content":{"rendered":"<h3>\n<p>Third dose of the vaccine appears to boost level of protection from about 35 percent to about 75 percent<\/p>\n<\/h3>\n<p><b><\/b><\/p>\n<p><b><\/b><\/p>\n<p>MONDAY, Dec. 13, 2021 (HealthDay News) &#8212; The ability of two-dose COVID-19 vaccines to protect against symptomatic infection by the omicron variant falls significantly short, but a booster shot provides considerable protection, according to the <a href=\"https:\/\/khub.net\/documents\/135939561\/430986542\/Effectiveness+of+COVID-19+vaccines+against+Omicron+variant+of+concern.pdf\/f423c9f4-91cb-0274-c8c5-70e8fad50074\" target=\"_blank\" rel=\"noopener\">first real-world study<\/a> of how effective vaccines are against the rapidly spreading new form of the coronavirus. The findings are preliminary and have not been peer-reviewed or published in a scientific journal.<\/p>\n<p>Four months after their second dose of the Pfizer-BioNTech vaccine, people had only about 35 percent protection against symptomatic infection by omicron, which is significantly lower than against the delta variant, British government scientists said. But a third dose of the vaccine boosted that level of protection to about 75 percent, according to the study published Friday, <em>The New York Times<\/em> reported. Several months after vaccination, two doses of the AstraZeneca vaccine provided virtually no protection against symptomatic infection from omicron, but a booster dose of the Pfizer vaccine increased protection to 71 percent.<\/p>\n<p>Despite their findings, the researchers said they expect that the vaccines will still provide an important defense against omicron-related hospitalizations and death, <em>The Times <\/em>reported.<\/p>\n<p>Omicron cases in England are doubling every 2.5 days. By mid-December, omicron could overtake delta in the United Kingdom and, without any precautionary measures, cause COVID-19 cases to soar, according to government scientists.<\/p>\n<p>A computer modeling study of England released on Saturday suggests that even in populations with high levels of immunity, omicron could cause significant societal disruptions and overwhelm hospitals, <em>The Times<\/em> reported. A person infected with omicron is about three times more likely than someone infected with delta to pass the virus to other members of his or her household, and a close contact of someone with omicron is about two times more likely than a close contact of someone with delta to become infected, according to the Health Security Agency in Britain.<\/p>\n<p><a href=\"https:\/\/www.nytimes.com\/2021\/12\/12\/health\/britain-omicron.html\" target=\"_blank\" rel=\"noopener\"><em>The New York Times<\/em> Article<\/a><\/p>\n<p><i><\/i><\/p>\n<p><i>Copyright \u00a9 2021 <a href=\"https:\/\/www.healthday.com\/\" target=\"_new\" rel=\"noopener\">HealthDay<\/a>. All rights reserved.<\/i><\/p>\n","protected":false},"excerpt":{"rendered":"<p>Third dose of the vaccine appears to boost level of protection from about 35 percent to about 75 percent<\/p>\n","protected":false},"author":6,"featured_media":69514,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[6],"tags":[11],"class_list":["post-69314","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-news","tag-news"],"_links":{"self":[{"href":"https:\/\/medgoo.com\/index.php\/wp-json\/wp\/v2\/posts\/69314","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/medgoo.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/medgoo.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/medgoo.com\/index.php\/wp-json\/wp\/v2\/users\/6"}],"replies":[{"embeddable":true,"href":"https:\/\/medgoo.com\/index.php\/wp-json\/wp\/v2\/comments?post=69314"}],"version-history":[{"count":0,"href":"https:\/\/medgoo.com\/index.php\/wp-json\/wp\/v2\/posts\/69314\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/medgoo.com\/index.php\/wp-json\/wp\/v2\/media\/69514"}],"wp:attachment":[{"href":"https:\/\/medgoo.com\/index.php\/wp-json\/wp\/v2\/media?parent=69314"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/medgoo.com\/index.php\/wp-json\/wp\/v2\/categories?post=69314"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/medgoo.com\/index.php\/wp-json\/wp\/v2\/tags?post=69314"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}